E-cigarettes Show Lower Cell Toxicity Than Traditional Cigarettes

Nov.18.2022
E-cigarettes Show Lower Cell Toxicity Than Traditional Cigarettes
The study found that e-cigarettes have less impact on cells than traditional cigarettes, using extracellular vesicle proteomics for analysis.

On November 5th, a research team led by Associate Researcher Yu Suhong from Fuzhou University published a paper in the authoritative global toxicology journal, "Toxicology in Vitro," which found that the impact of electronic cigarettes on cells is significantly lower than that of traditional cigarettes.


The study used exosome proteomics for the first time to compare the effects of electronic cigarettes and traditional cigarettes on human bronchial epithelial cells. Exosomes are small membrane vesicles containing complex RNA and proteins, which can be used as biomarkers for early diagnosis and prognosis evaluation of diseases such as cancer.


Research data shows that cigarette tar leads to more differences in protein expression of extracellular vesicles within cells, and these are significantly enriched in cancer signaling pathways. Meanwhile, differences caused by e-cigarettes are less pronounced. Toxicology studies have also found that cigarette tar significantly inhibits cell activity, while e-cigarette tar did not produce similar negative effects, indicating that the cellular toxicity of e-cigarettes is relatively low.


The paper was published in the toxicology SCI journal, "In Vivo Toxicology.


In recent years, several studies have found that electronic cigarettes may be a form of harm reduction product.


In 2021, the Pennsylvania State University College of Medicine published a paper in Cancer stating that e-cigarettes could be effective tools for quitting smoking and also decrease the production of carcinogens in smokers' lungs. In 2022, an editorial in Nature suggested that for patients with gum health concerns, e-cigarettes may be a safer nicotine substitute and could reduce the risk of oral cancer.


According to Associate Researcher Yu Suhong, this study is the first to systematically analyze the safety of cigarettes and e-cigarettes starting from extracellular vesicles, filling a gap in the relevant field.


According to research findings, electronic cigarettes are less harmful than traditional cigarettes and may be a reduced-harm product," said Yu Suhong. However, electronic cigarettes are not entirely safe and should not be used by non-smokers.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PMI says Colorado ZYN plant build advances as first pouches hit market in 2025
PMI says Colorado ZYN plant build advances as first pouches hit market in 2025
Philip Morris International (PMI) is investing $600 million to build a ZYN nicotine pouch plant in Aurora, Colorado. While the facility is still under construction, PMI said production started in September 2025 and the first pouches made at the site have already gone to market.
Feb.10 by 2FIRSTS.ai
Product | Vaporesso lists Vibe SE 2 on official site, offering leather/plated versions and a 1,400mAh battery
Product | Vaporesso lists Vibe SE 2 on official site, offering leather/plated versions and a 1,400mAh battery
Vaporesso has recently listed the Vibe SE 2, a new device in its Vibe series, on the brand’s official website. The product is positioned as an entry-level MTL device and features a 1,400mAh built-in battery with Type-C 1A charging. It is available in two finishes—Leather and Plated—while listings on online retail channels show prices of around $17.99 and £22.99.
Jan.30 by 2FIRSTS.ai
Singapore sentencing: 17,000+ vape pods seized; man convicted of multiple offences
Singapore sentencing: 17,000+ vape pods seized; man convicted of multiple offences
A 28-year-old man in Singapore was sentenced on Jan 22 after admitting to six offences spanning 2021 to 2024, including possessing vapes and vape pods for sale.
Jan.23 by 2FIRSTS.ai
After Export Tax Rebates Go to Zero: How China’s E-Cigarette Supply Chain Is Being Reshaped, According to 2Firsts Research
After Export Tax Rebates Go to Zero: How China’s E-Cigarette Supply Chain Is Being Reshaped, According to 2Firsts Research
China’s e-cigarette industry is adjusting to a major policy shift. From April 1, 2026, China will scrap the 13% export VAT rebate on e-cigarette products, a move affecting manufacturers centered in Shenzhen. Industry participants told 2Firsts the change is forcing a reassessment of pricing and capacity, with competition shifting toward cash flow resilience, regulatory compliance, and multi-location strategies.
Industry Insight
Jan.16
Guam DOE: Police to respond to all school-campus incidents involving minors and nicotine products
Guam DOE: Police to respond to all school-campus incidents involving minors and nicotine products
According to the Guam Department of Education (GDOE), police officers will now assist in handling incidents involving minor students who vape or use tobacco products on public school campuses, and cases may be forwarded to the Office of the Attorney General.
Jan.15 by 2FIRSTS.ai
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11